Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Hernia
Published in: Hernia 2/2021

01-04-2021 | Abdominal Surgery | Letter to the Editor

The use of deep neuromuscular blockade and reversal in ventral hernia surgery

Authors: R. L. Harries, N. J. Smart

Published in: Hernia | Issue 2/2021

Login to get access

Excerpt

The use of deep neuromuscular blockade (NMB) (defined as train-of-four (TOF) count 0 and post-tetanic count (PTC) < 5) may improve surgical conditions during ventral hernia surgery, yet anaesthetists may have reluctance towards its use. Traditionally it has been associated with longer reversal times and incomplete recovery of NMB, which can lead to respiratory complications. However, the introduction of novel neuromuscular blockade reversal agents (e.g. sugammadex) has enabled rapid and effective reversal in patients with deep NMB, when compared to neostigmine, but this comes at a cost financially. …
Literature
1.
Park S, Son YG, Yoo S, Lim T, Kim WH, Kim J (2018) Deep vs. moderate neuromuscular blockade during laparoscopic surgery; a systematic review and meta-analysis. Eur J Anaesthesiol 35:867–875CrossRef
2.
Bruintjes MH, van Helden EV, Braat AE, Dahan AE, Scheffer GJ, van Laarhoven CJ, Warle MC (2017) Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery; a systematic review and meta-analysis. Br J Anaesth 118(6):834–842CrossRef
3.
Söderström CM, Borregaard Medici R, Assadzadeh S, Følsgaard S, Rosenberg J, Gätke MR, Madsen MV (2018) Deep neuromuscular blockade and surgical conditions during laparoscopic ventral hernia repair: A randomised, blinded study. Eur J Anaesthesiol 35:876–882CrossRef
4.
Madsen MV, Scheppan S, Mørk E, Kissmeyer P, Rosenberg J, Gätke MR (2017) Influence of deep neuromuscular block on the surgeon’s assessment of surgical conditions during laparotomy: a randomized controlled double blinded trial with rocuronium and sugammadex. Br J Anaesth 119(3):435–442CrossRef
5.
Oh TK, Oh A, Ryu J, Koo B, Song A, Nam SW, Jee H (2019) Retrospective analysis of 30-day unplanned readmission after major abdominal surgery with reversal by sugammadex or neostigmine. Br J Anaesth 122(3):370–378CrossRef
Metadata
Title
The use of deep neuromuscular blockade and reversal in ventral hernia surgery
Authors
R. L. Harries
N. J. Smart
Publication date
01-04-2021
Publisher
Springer Paris
Published in
Hernia / Issue 2/2021
Print ISSN: 1265-4906
Electronic ISSN: 1248-9204
DOI
https://doi.org/10.1007/s10029-020-02132-7

Other articles of this Issue 2/2021

Hernia 2/2021 Go to the issue

How-I-Do-It

Totally endoscopic sublay (TES) repair for lateral abdominal wall hernias: technique and first results

Original Article

Implementing preoperative Botulinum toxin A and progressive pneumoperitoneum through the use of an algorithm in giant ventral hernia repair

How-I-Do-It

Signs and landmarks in eTEP Rives-Stoppa repair of ventral hernias

Original Article

What are the trends in incisional hernia repair? Real-world data over 10 years from the Herniamed registry

Original Article

Robotic ventral hernia repair: a safe and durable approach

Original Article

Comparing the outcomes of external oblique and transversus abdominus release using the AHSQC database